Panbela Therapeutics
(OTC) PBLA
Panbela Therapeutics Financials at a Glance
Market Cap
$53.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$27.91M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
3309.47 (High)
Dividend
$0.00
Beta (Volatility)
3309.47 (High)
Price
$0.01
Volume
365
Open
$0.01
Price
$0.01
Volume
365
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.01 - $2.50
Estimated Earnings Date
Aug 12, 2026
Dividend
$0.00
Beta (Volatility)
3309.47 (High)
Price
$0.01
Volume
365
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.01 - $2.50
Estimated Earnings Date
Aug 12, 2026
PBLA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Panbela Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
Jennifer K. Simpson, PhD
Website
www.panbela.comHeadquarters
Waconia, MN 55387, US
PBLA Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
396.00%
Return on Capital
-10597.93%
Return on Assets
-214.06%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$53.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
4.85M
Volume
365
Avg. Volume
1.28K
Financials (TTM)
Gross Profit
-$29.04M
Operating Income
-$36.20M
EBITDA
-$26.40M
Operating Cash Flow
-$15.57M
Capital Expenditure
$0.00
Free Cash Flow
-$15.57M
Cash & ST Invst.
$142.00K
Total Debt
$6.39M
Panbela Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$7.17M
+8.7%
Gross Margin
0.00%
N/A
Market Cap
$53.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$7.70K
N/A
Employees
7
N/A
Net Income
-$7.17M
+8.4%
EBITDA
-$6.73M
+13.5%
Quarterly Fundamentals
Total Cash
$142.00K
-84.3%
Total Debt
$6.39M
+23.1%
Accounts Receivable
$332.00K
+114.2%
Inventory
$0.00
N/A
Long Term Debt
$3.19M
-23.8%
Short Term Debt
$3.20M
+220.0%
Return on Assets
-2.14%
N/A
Return on Invested Capital
99.41%
N/A
Free Cash Flow
-$2.12M
+68.2%
Operating Cash Flow
-$2.12M
+68.2%